PEAR1, PON1, CYP2C19, CYP1A2 and F2R Polymorphisms are Associated with MACE in Clopidogrel-Treated Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
Pengqiang Du,1 Xingang Li,2 Dandan Li,2 Yongcheng Ma,1 Ming Ni,1 Yafei Li,1 Wenbo Li,3 Aifeng Wang,1 Xiaowei Xu4 1Department of Pharmacy, Fuwai Central China Cardiovascular Hospital, Henan Provincial People’s Hospital, Central China Fuwai Hospital of Zhengzhou University, Zhengzhou, 450003, People’s...
Saved in:
| Main Authors: | Du P, Li X, Li D, Ma Y, Ni M, Li Y, Li W, Wang A, Xu X |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2024-12-01
|
| Series: | Pharmacogenomics and Personalized Medicine |
| Subjects: | |
| Online Access: | https://www.dovepress.com/pear1-pon1-cyp2c19-cyp1a2-and-f2r-polymorphisms-are-associated-with-ma-peer-reviewed-fulltext-article-PGPM |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The role of CYP2C19*2 variant and other factors in clopidogrel resistance in Montenegrin ACS patients
by: Svetlana Perović, et al.
Published: (2024-11-01) -
Clopidogrel Versus Aspirin as Chronic Maintenance Antiplatelet Monotherapy in Patients After Percutaneous Coronary Intervention With Chronic Kidney Disease: A Post Hoc Analysis of the HOST‐EXAM Trial
by: Jeehoon Kang, et al.
Published: (2024-09-01) -
CYP2C19 polymorphism and coronary in-stent restenosis: A systematic review and meta-analysis [version 3; peer review: 2 approved, 1 approved with reservations]
by: Ivana Purnama Dewi, et al.
Published: (2025-01-01) -
Long-term cost-effectiveness of ticagrelor versus clopidogrel in acute coronary syndrome in Spain
by: E. Molina-Cuadrado, et al.
Published: (2014-07-01) -
Research progress on coronary slow flow or no-reflow of coronary heart disease undergoing percutaneous coronary intervention surgery
by: Mengdi Wang, et al.
Published: (2025-01-01)